• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个与免疫相关的四个长非编码 RNA 标志物作为宫颈癌的预测指标。

A four immune-related long noncoding RNAs signature as predictors for cervical cancer.

机构信息

Hongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, No.1111, XianXia Road, Shanghai, 200336, China.

Obstetrics and Gynecology Department, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, No.1111, XianXia Road, Shanghai, 200336, China.

出版信息

Hum Cell. 2022 Jan;35(1):348-359. doi: 10.1007/s13577-021-00654-5. Epub 2021 Nov 30.

DOI:10.1007/s13577-021-00654-5
PMID:34846702
Abstract

The progression, metastasis, and prognosis of cervical cancer (CC) is influenced by the tumor immune microenvironment. Studies proved that long non-coding RNAs (lncRNAs) to engage in cervical cancer development, especially immune-related lncRNAs, have emerged crucial in the tumor immune process. This study was set out to identify an immune-related lncRNA signature. In total, 13,838 lncRNA expression profiles and 328 immune genes were acquired from the clnical data of 306 CC tissues and 3 non-CC tissues. From the 433 identified immune-related lncRNAs, 4 candidate immune-related lncRNAs (SOX21-AS1, AC005332.4, NCK1-DT, LINC01871) were considered independent indicators of cervical cancer prognosis through the univariate and multivariate Cox regression analysis, and they were used to construct a prognostic and survival lncRNA signature model followed by the bootstrap method for further verification. Kaplan-Meier curves illustrated that cervical cancer patients could be divided into high-risk and low-risk groups with significant differences (P = 2.052e - 05), and the discrepancy of immune profiles between these two risk groups was illustrated by principal components analysis. Taken together, the novel survival predictive model created by the four immune-related lncRNAs showed promising clinical prediction value in cervical cancer.

摘要

宫颈癌(CC)的进展、转移和预后受肿瘤免疫微环境影响。研究证实,长链非编码 RNA(lncRNA)参与宫颈癌的发生,尤其是免疫相关 lncRNA,在肿瘤免疫过程中起着至关重要的作用。本研究旨在确定一个免疫相关的 lncRNA 特征。总共从 306 个 CC 组织和 3 个非 CC 组织的临床数据中获得了 13838 个 lncRNA 表达谱和 328 个免疫基因。在 433 个鉴定出的免疫相关 lncRNA 中,通过单变量和多变量 Cox 回归分析,将 4 个候选免疫相关 lncRNA(SOX21-AS1、AC005332.4、NCK1-DT、LINC01871)视为宫颈癌预后的独立指标,并使用 Bootstrap 方法进一步验证构建预后和生存 lncRNA 特征模型。Kaplan-Meier 曲线表明,宫颈癌患者可以分为高风险和低风险组,两组间的差异具有统计学意义(P=2.052e-05),并且通过主成分分析可以说明这两个风险组之间的免疫谱差异。总之,由这四个免疫相关 lncRNA 构建的新的生存预测模型在宫颈癌中具有良好的临床预测价值。

相似文献

1
A four immune-related long noncoding RNAs signature as predictors for cervical cancer.一个与免疫相关的四个长非编码 RNA 标志物作为宫颈癌的预测指标。
Hum Cell. 2022 Jan;35(1):348-359. doi: 10.1007/s13577-021-00654-5. Epub 2021 Nov 30.
2
Identification of cuproptosis-related lncRNA for predicting prognosis and immunotherapeutic response in cervical cancer.鉴定铜死亡相关 lncRNA 预测宫颈癌的预后和免疫治疗反应。
Sci Rep. 2023 Jul 3;13(1):10697. doi: 10.1038/s41598-023-37898-0.
3
Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.长链非编码 RNA SOX21-AS1 通过竞争性吸附 miR-7/VDAC1 促进宫颈癌进展。
J Cell Physiol. 2019 Aug;234(10):17494-17504. doi: 10.1002/jcp.28371. Epub 2019 Mar 25.
4
Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.lncRNA SOX21-AS1 的低甲基化在宫颈癌中具有临床预后价值。
Life Sci. 2019 Sep 15;233:116708. doi: 10.1016/j.lfs.2019.116708. Epub 2019 Jul 29.
5
[Correlation analysis of Poor Prognosis and Immunotherapy of lncRNAs Related with m A Modification in Cervical Cancer].[宫颈癌中与m⁶A修饰相关的lncRNAs的预后不良与免疫治疗的相关性分析]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Jul;53(4):626-636. doi: 10.12182/20220760504.
6
Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.鉴定 m6A 甲基转移酶相关的长链非编码 RNA 特征,以预测肝细胞癌患者的免疫治疗和预后。
Biosci Rep. 2021 Jun 25;41(6). doi: 10.1042/BSR20210760.
7
The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.高危型人乳头瘤病毒相关长非编码 RNA 在宫颈鳞癌预后中的作用。
DNA Cell Biol. 2020 Apr;39(4):645-653. doi: 10.1089/dna.2019.5167. Epub 2020 Feb 11.
8
Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.鉴定五个与免疫相关的 lncRNAs,用于预测乳腺癌患者的生存和肿瘤微环境特征。
Comput Math Methods Med. 2021 Feb 27;2021:6676692. doi: 10.1155/2021/6676692. eCollection 2021.
9
Constructing a Novel Signature Based on Immune-Related lncRNA to Improve Prognosis Prediction of Cervical Squamous Cell Carcinoma Patients.构建基于免疫相关 lncRNA 的新型标志物,改善宫颈鳞状细胞癌患者的预后预测。
Reprod Sci. 2022 Mar;29(3):800-815. doi: 10.1007/s43032-022-00851-z. Epub 2022 Jan 24.
10
Prognosis Analysis and Validation of Fatty Acid Metabolism-Related lncRNAs and Tumor Immune Microenvironment in Cervical Cancer.宫颈癌中脂肪酸代谢相关 lncRNAs 与肿瘤免疫微环境的预后分析与验证
J Immunol Res. 2022 Jul 28;2022:4954457. doi: 10.1155/2022/4954457. eCollection 2022.

引用本文的文献

1
LINC01871 facilitates cervical cancer cell migration and immune escape by targeting miR-873-3p/MAP3K2 axis.LINC01871通过靶向miR-873-3p/MAP3K2轴促进宫颈癌细胞迁移和免疫逃逸。
Kaohsiung J Med Sci. 2025 Apr;41(4):e12948. doi: 10.1002/kjm2.12948. Epub 2025 Mar 4.
2
Bidirectional recurrent neural network approach for predicting cervical cancer recurrence and survival.用于预测宫颈癌复发和生存的双向递归神经网络方法
Sci Rep. 2024 Dec 30;14(1):31641. doi: 10.1038/s41598-024-80472-5.
3
Comprehensive analysis of disulfidptosis-related lncRNA features for prognosis and immune landscape prediction in colorectal cancer.

本文引用的文献

1
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma.肿瘤与免疫重编程在晚期肾细胞癌免疫治疗中的作用
Cancer Cell. 2021 May 10;39(5):649-661.e5. doi: 10.1016/j.ccell.2021.02.015. Epub 2021 Mar 11.
2
Identification of autophagy-related long non-coding RNA prognostic signature for breast cancer.鉴定乳腺癌自噬相关长非编码 RNA 预后特征。
J Cell Mol Med. 2021 Apr;25(8):4088-4098. doi: 10.1111/jcmm.16378. Epub 2021 Mar 10.
3
An Integrated Autophagy-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial Cancer: A Bioinformatics-Based Approach.
用于预测结直肠癌预后和免疫格局的二硫化物驱动细胞焦亡相关长链非编码RNA特征的综合分析
Front Oncol. 2023 Dec 27;13:1287808. doi: 10.3389/fonc.2023.1287808. eCollection 2023.
4
Identification of AP002498.1 and LINC01871 as prognostic biomarkers and therapeutic targets for distant metastasis of colorectal adenocarcinoma.鉴定 AP002498.1 和 LINC01871 作为结直肠腺癌远处转移的预后生物标志物和治疗靶点。
Cancer Med. 2024 Jan;13(1):e6823. doi: 10.1002/cam4.6823. Epub 2023 Dec 11.
5
Association of Glycosylation-Related Genes with Different Patterns of Immune Profiles and Prognosis in Cervical Cancer.糖基化相关基因与宫颈癌不同免疫谱模式及预后的关联
J Pers Med. 2023 Mar 15;13(3):529. doi: 10.3390/jpm13030529.
6
Comprehensive analysis of cuproptosis-related lncRNAs model in tumor immune microenvironment and prognostic value of cervical cancer.肿瘤免疫微环境中铜死亡相关长链非编码RNA模型的综合分析及其对宫颈癌的预后价值
Front Pharmacol. 2022 Nov 30;13:1065701. doi: 10.3389/fphar.2022.1065701. eCollection 2022.
7
Dysregulated long non-coding RNA in Sjögren's disease impacts both interferon and adaptive immune responses.干燥综合征中失调的长非编码 RNA 影响干扰素和适应性免疫反应。
RMD Open. 2022 Nov;8(2). doi: 10.1136/rmdopen-2022-002672.
8
Development and validation of an autophagy-related long non-coding RNA prognostic signature for cervical squamous cell carcinoma and endocervical adenocarcinoma.一种用于宫颈鳞状细胞癌和宫颈内膜腺癌的自噬相关长链非编码RNA预后标志物的开发与验证
Front Oncol. 2022 Nov 3;12:1049773. doi: 10.3389/fonc.2022.1049773. eCollection 2022.
9
SOX21-AS1 activated by STAT6 promotes pancreatic cancer progression via up-regulation of SOX21.SOX21-AS1 通过激活 STAT6 促进胰腺癌细胞的进展,上调 SOX21 的表达水平。
J Transl Med. 2022 Nov 5;20(1):511. doi: 10.1186/s12967-022-03521-5.
10
Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma.宫颈鳞状细胞癌和宫颈管腺癌中一种新型坏死性凋亡相关预后标志物的鉴定与验证
Front Oncol. 2022 Sep 16;12:1011000. doi: 10.3389/fonc.2022.1011000. eCollection 2022.
基于生物信息学的方法:整合自噬相关长非编码 RNA 特征作为人类子宫内膜癌的预后生物标志物。
Biomed Res Int. 2020 Dec 12;2020:5717498. doi: 10.1155/2020/5717498. eCollection 2020.
4
Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.免疫相关长链非编码RNA作为乳腺癌生存的预测指标:一种预后特征
J Transl Med. 2020 Nov 23;18(1):442. doi: 10.1186/s12967-020-02522-6.
5
Long Noncoding RNAs, New Critical Regulators in Cancer Immunity.长链非编码RNA,癌症免疫中的新型关键调节因子。
Front Oncol. 2020 Oct 30;10:550987. doi: 10.3389/fonc.2020.550987. eCollection 2020.
6
A Seven Immune-Related lncRNAs Model to Increase the Predicted Value of Lung Adenocarcinoma.一种用于提高肺腺癌预测价值的七种免疫相关长链非编码RNA模型。
Front Oncol. 2020 Oct 14;10:560779. doi: 10.3389/fonc.2020.560779. eCollection 2020.
7
Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity.儿科全中枢神经系统肿瘤免疫细胞浸润分析鉴定抗肿瘤免疫的相关因素。
Nat Commun. 2020 Aug 28;11(1):4324. doi: 10.1038/s41467-020-18070-y.
8
Identification of a TLR-Induced Four-lncRNA Signature as a Novel Prognostic Biomarker in Esophageal Carcinoma.TLR诱导的四个lncRNA特征作为食管癌新型预后生物标志物的鉴定
Front Cell Dev Biol. 2020 Jul 21;8:649. doi: 10.3389/fcell.2020.00649. eCollection 2020.
9
Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic.非小细胞肺癌脑转移患者的免疫治疗。了解脑肿瘤微环境并剖析临床免疫检查点阻断治疗的结果。
Cancer Treat Rev. 2020 Sep;89:102067. doi: 10.1016/j.ctrv.2020.102067. Epub 2020 Jul 7.
10
Immunotherapy in Anal Cancer.肛门癌的免疫治疗。
Curr Oncol Rep. 2020 Jul 11;22(9):94. doi: 10.1007/s11912-020-00946-3.